Celldex Therapeutics, Inc.401(k)
CELLDEX THERAPEUTICS, INC. EMPLOYEE SAVINGS PLAN · NEEDHAM, MA · plan year 2025
Peer grade: B+ · admin costs + employer contributions vs same-size plans · how grading works
Celldex Therapeutics, Inc. reported $12,618 in plan administrative expenses for 2025: 0.02% of average plan assets, lower than ~75% of peers. Employer contributions averaged $3,034 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 3 years on file its reported administrative ratio rose from 0.01% to 0.02%. The plan sits in the $50M–$250M size bracket, benchmarked here against 605 comparable plans and shown alongside other manufacturing employers. By assets it is the 576th-largest of 2,726 plans among Massachusetts employers on file, and the 2,599th of 13,661 in manufacturing. In 2025, employees put in $4.90 for every $1.00 the employer contributed; active participation has grown from 147 to 196 since 2022.
Celldex Therapeutics, Inc.'s 2025 employer contribution ran below the $4,093 median for plans its size. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2025 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 133191702 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.